کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
10520534 | 954185 | 2013 | 8 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Transfusion de plasma : produits-indications
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
Plasma thérapeutiqueMassive transfusion - انتقال خون عظیمTransfusion massive - انتقال خون عظیم استRecommandations - توصیهhémorragies - خون ریزیHaemorrhage - خونریزیfresh frozen plasma - پلاسما تازه منجمدPlasma frais congelé - پلاسما تازه منجمدTherapeutic plasma - پلاسما درمانیGuidelines - گایدلاین یا دستورالعمل
موضوعات مرتبط
علوم زیستی و بیوفناوری
ایمنی شناسی و میکروب شناسی
ایمونولوژی
پیش نمایش صفحه اول مقاله

چکیده انگلیسی
The use of therapeutic plasma has increased in France by more than 40% since 2002. This growth may be explained by the improvement in transfusion safety, the diminution of the risk of transmission of pathogens and the regained confidence of the physicians in blood products. Therapeutic plasma also benefits from additional procedures to reduce infectious (securisation) or immunological risks (selection of blood donors). Its application in massive transfusions has undergone a significant evolution over the last few years. A proactive attitude favouring early and important use of plasma on the basis of pre-established protocols is advocated henceforth. The prescription of therapeutic plasma for other indications must be guided by the results of biological tests and an evaluation of the haemorrhagic risk. Despite regular updating of the guidelines for good transfusion practice, plasma is still sometimes prescribed for prophylactic purposes in situations where the biological and/or clinical criteria do not justify it. Moreover, it is not recommended to use fresh frozen plasma in cases of deficiency of coagulation factors if the specific concentrates are available as intravenous fluids. Complementary clinical studies will be necessary to evaluate, in certain indications, the real benefits of the transfusion of plasma and the interest of replacing it by concentrates of coagulant factors (fibrinogen, prothrombin complex).
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Transfusion Clinique et Biologique - Volume 20, Issue 2, May 2013, Pages 47-54
Journal: Transfusion Clinique et Biologique - Volume 20, Issue 2, May 2013, Pages 47-54
نویسندگان
R. Djoudi,